Laddar populära aktier...
- Sales -6% y-o-y, -12% vs. ABGSCe - EBIT of SEK 49m, +12% vs.
Redeye comments on SHH´s second quarter of the year.
Redeye retains its positive view on Lagercrantz following a Q1 report in-line with our estimates.
Svedbergs Group posted a solid set of Q2 2024 numbers, with sales coming in-line with our estimates ...
- Net sales SEK 562m, 0% vs ABGSCe and Factset cons.
Doro delivered better than expected Q2 report on all key metrics.
Cibus' Q2 2024 income from property management (IFPM) was 6% above Infront consensus, but the result...
- '24e-'26e adj. EBITA down 3-2% - Increasingly likely that Q3'24 will be the trough - NTM EV/EBITA ...
- Q2e: 21% ARR growth and adj. EBITDA of DKK 1.1m - '24e likely to be even more back-end loaded vs.
- Rec. PTP 7% below ABGSCe - CEPS est. +2.7-0.6% for '25-26e due to projects - Share trading at a ~3...
Cibus posted Q2 results largely in line with expectations.
- 10% beat on EBITDA vs cons - Strong growth in Technology, but continued weakness in Genetics - Est...
Consti reports its Q2 results on Friday 19th of July.
- EBIT SEK 131m (-11% vs. ABGSCe, -4% vs. FactSet cons) - We expect consensus EBIT to come down by 2...
Redeye updates its estimates and valuation following Serstech's Q1 2024 report.
